Fractyl Health Announces Groundbreaking Data from REMAIN-1 Midpoint Cohort Showing Revita Maintained Weight Loss After GLP-1 Discontinuation
RefinitivThời gian đọc: dưới 1 phút
Fractyl Health Inc GUTS:
FRACTYL HEALTH ANNOUNCES GROUNDBREAKING DATA FROM REMAIN-1 MIDPOINT COHORT SHOWING REVITA® MAINTAINED WEIGHT LOSS AFTER GLP-1 DISCONTINUATION
FRACTYL HEALTH INC - STUDY MET 3-MONTH EFFICACY ENDPOINT WITH STRONG STATISTICAL SIGNIFICANCE
FRACTYL HEALTH INC - REVITA PROCEDURE DEMONSTRATED EXCELLENT SAFETY AND TOLERABILITY TO DATE
Đăng nhập hoặc tạo tài khoản miễn phí trọn đời để đọc tin tức này